Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Summary

Study ROR-PH-302, ADVANCE CAPACITY, was designed to evaluate the effects of ralinepag therapy on exercise capacity as assessed by change in peak oxygen consumption (VO2) derived from cardiopulmonary exercise testing (CPET) after 28 weeks of treatment.

Timeline

Start

2021-01-20

Primary completion

2023-04-12

Completion

2023-04-12

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications